1,3-Benzodioxole 98%

WELCOME TO Catapharma
The future is always UNKNOWN, but with the commitment to put technical and commercial proficiencies at the service of our esteemed customers, it looks BRIGHT!!!

The Catapharma Group was formed in 1986 with the coming together of three young chemical engineers with a strong desire to apply their technical skills to productive industrial activity.

Dr. Shrikant Karwa, the founder of the Group, has, to his credit, a doctoral thesis on Principles of Liquid-phase Catalytic Hydrogenation and international publications and review articles in the same field. With no industrial experience and only his university research as his asset, he directly ventured to transform his technological insight into industrial reality.

Presently, the group comprises of 110 people with an annual turnover of $ 9 million. The core activity is the manufacture of pharmaceutical intermediates and fine chemicals. This is backed up by a well-equipped research lab and pilot plant for the development of new products and up-gradation of existing processes.